This e-presentation explains the regulatory specificities of biosimilars in the context of competition law and gives an overview of the expected strategies of the pharmaceutical industry to restrict competition of biosimilars on the market.
e-Presentation | March 2020 | Learning time: 34 minutes
Nicolas Pourbaix
Watch the premium version Purchase the premium version